What is the recommended corticosteroid regimen for sudden sensorineural hearing loss caused by acoustic trauma?

Recommended Corticosteroid Regimen for Acoustic Trauma-Induced Sudden Hearing Loss

For sudden sensorineural hearing loss caused by acoustic trauma, initiate oral prednisolone 60 mg daily (or 1 mg/kg/day, max 60 mg) for 10 days, then taper over 4 days, starting within 24 hours of injury for optimal outcomes.

Treatment Algorithm

Timing is Critical

• Initiate treatment within 24 hours when possible, ideally within the first 7 days 1, 2
• Treatment started within 14 days still shows benefit, but early intervention (within 7 days) demonstrates significantly superior hearing recovery 3, 2, 4
• Benefit has been reported up to 6 weeks post-onset, though outcomes diminish with delay 3

Specific Dosing Regimen

Oral Systemic Steroids (First-line):

• Prednisolone 60 mg daily for 10 days, then taper over 4 days 5
  • This 14-day regimen showed significantly better hearing gain compared to shorter courses (p = 0.03) 5
  • Alternative: Prednisone 1 mg/kg/day (max 60 mg) for 7-14 days, then taper over similar period 3
  • Alternative: Methylprednisolone 48 mg/day or Dexamethasone 10 mg/day 3

Key Evidence: A 2019 study specifically examining acoustic trauma from gunshot exposure demonstrated that the 14-day regimen (60 mg × 10 days + 4-day taper) produced significantly more hearing improvement than a 10-day regimen (60 mg × 5 days + 5-day taper) in multivariable analysis (R² = 0.51, p < 0.001) 5.

Intratympanic Steroids (Alternative or Salvage)

When to Use:

• Contraindications to systemic steroids (insulin-dependent diabetes, poorly controlled hypertension, glaucoma, peptic ulcer disease) 3
• Salvage therapy after incomplete recovery from initial treatment 3
• Can be used as initial therapy with non-inferior efficacy to systemic steroids 3

Dosing:

• Dexamethasone 24 mg/mL (compounded) or 10 mg/mL (stock), OR Methylprednisolone 40 mg/mL or 30 mg/mL 3
• Inject 0.4-0.8 mL into middle ear space
• Up to 4 injections over 2-week period 3
• Keep head in otologic position (affected ear up) for 15-30 minutes per injection 3

Adjunctive Hyperbaric Oxygen Therapy

Consider HBOT combined with steroids when:

• Treatment can be initiated within 7 days of acoustic trauma 2
• Severe or profound hearing loss present 3
• Available within 2 weeks as initial therapy or within 1 month as salvage 3

Evidence for Acoustic Trauma: A 2025 study demonstrated that combined HBOT + corticosteroids initiated within 7 days produced significantly better outcomes than delayed treatment (post-treatment high-frequency PTA: 21.93 dB vs 31.19 dB, p < 0.05) 2. The combination showed high-frequency PTA improvement from 40.26 dB to 24.99 dB (p < 0.0001) 2.

Expected Outcomes Based on Severity

Prognostic Factors:

• Patients with worse initial hearing loss (>35 dB) benefit most from early steroid treatment, showing 13-14 dB improvement in bone conduction at 3-4 kHz and additional 7-8 dB improvement in air conduction at 6-8 kHz compared to no treatment 1
• Early treatment (<24 hours) with high-dose steroids for ≥7 days demonstrates significantly better outcomes 1
• Severe hearing loss has worse odds of complete recovery (OR = 0.10) compared to mild loss 4

Critical Monitoring and Caveats

Monitor for Common Adverse Effects:

• Hyperglycemia (up to 29.8% of patients) and hypertension (up to 37.9%) - particularly in patients with pre-existing diabetes or hypertension 6
• Gastric irritation (up to 27.9%) and mood disturbances (up to 44.6%) 6
• Consider gastroprotection and monitor glucose/blood pressure in susceptible patients 3, 6

Audiometric Follow-up:

• Obtain audiogram at completion of treatment course 3
• Follow-up audiometry within 6 months of initial diagnosis 3
• Interval audiograms between intratympanic injections may guide early termination if hearing resolves 3

Important Pitfall: The guideline acknowledges that evidence for steroids versus placebo remains mixed, with some RCTs showing no benefit 3. However, given the devastating impact on quality of life and the potential for even modest hearing improvement, treatment is justified despite uncertain evidence 3. The key is early initiation - this is where the strongest evidence exists for acoustic trauma specifically 5, 1, 2.

Shared Decision-Making: Given the mixed evidence base and potential adverse effects, discuss risks and benefits with patients, particularly those with diabetes, hypertension, or other contraindications 3. However, for acoustic trauma specifically, the recent evidence strongly favors early high-dose treatment 5, 1.